Skip to main content

Month: March 2022

Vera Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

Phase 2b ORIGIN clinical trial of atacicept on track, topline data expected Q4 2022 Acquired MAU868, a first-in-class monoclonal antibody to treat BK Virus infections, full results from interim analysis of Phase 2 study of MAU868 in kidney transplant recipients planned for mid-2022 Initiation of Phase 3 pivotal clinical trial of atacicept in lupus nephritis planned for 2H-2022 BK Virus and MAU868 key opinion leader webinar to be held Tuesday, March 29, 2022 Management to host business update webcast today at 8:00 a.m. ETBRISBANE, Calif., March 24, 2022 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today reported its business highlights and financial results for...

Continue reading

LAVA Therapeutics Provides Business Update and Reports Fourth Quarter and Year End 2021 Financial Results

LAVA-051 shows encouraging initial safety and pharmacodynamic observations; on track for more dose escalation data from Phase 1/2a trial in Q2 2022 LAVA-1207 Phase 1/2a trial in mCRPC on track to report initial data in H2 2022 New pipeline program: LAVA-1266, a CD123-directed Gammabody™ for hematological malignancies Strong balance sheet with cash and investments of $133.2 million as of December 31, 2021UTRECHT, The Netherlands and PHILADELPHIA, March 24, 2022 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq: LVTX), an immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma delta T cell engagers to transform the treatment of cancer, today announced recent corporate highlights and financial results for the fourth quarter and year ended December 31, 2021. “I am incredibly proud of...

Continue reading

Lantronix xPico 200 Series Wi-Fi IoT Gateways Achieve WPA3 Enterprise and Personal Certification

New features simplify and strengthen Wi-Fi security, enable more robust authentication and deliver increased cryptographic strength for highly sensitive data IRVINE, Calif., March 24, 2022 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of secure turnkey solutions for the Industrial Internet of Things (IoT) and Intelligent IT market, today announced that its xPico 270, xPico 250 and xPico 240 embedded Wi-Fi® IoT gateways have achieved WPA3™ Certification for WPA3-Enterprise and WPA3-Personal by the Wi-Fi Alliance. Delivering seamless and secure Ethernet, Wi-Fi and Bluetooth® connectivity, Lantronix xPico 200 Series gateways enable OEMs to build and deploy smart connected products with reduced complexity and lower risk. Designed to increase resiliency in mission-critical network applications, the new WPA3 features...

Continue reading

Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

Fourth Quarter 2021 Revenue of $65.9 million and Full Year 2021 Revenue of $209.3 million, Reflecting 22% Quarterly and 159% Annual Growth Expanded Cannabis Footprint to Seven States, Including Three Vertically Integrated Markets BOCA RATON, Fla., March 24, 2022 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, is pleased to announce its financial results for the fourth quarter 2021 (“Q4 2021”) and full year ended December 31, 2021 (“FY 2021”). All financial information is provided in U.S. dollars unless otherwise indicated. Financial Highlights Q4 2021Total revenue of $65.9 million, an increase of 22% sequentially and 104% year-over-year Adjusted gross profit(1) of $26.4 million, an increase of 8% sequentially and 76% year-over-year Net...

Continue reading

Industry Stand Out and Veteran Joining Koios Team as President of Conventional Sales

DENVER and VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — Koios Beverage Corp. (CSE: FIT; OTC: FITSF) (the “Company” or “Koios”) is pleased to announce that Ryon Shack, an industry veteran, will be joining the Koios team as President of Conventional Sales, effective immediately. Ryon Shack is originally from Nashville, Tennessee and holds a bachelors degree from Belmont university in Kinesiology. He has worked as a top sales producer in the supplement industry for almost 2 decades. Ryon oversaw and managed one of the top sales teams at Europa Sports, one of the largest supplement distributors in the US, for more than ten years. Ryon has a long standing and remarkable career in the supplement and food and beverage space. He was instrumental in helping Europa Sports build brands like Celsius...

Continue reading

Freeline Announces Updated Development Plan and Timelines for FLT190 for People with Fabry Disease

Company to progress to second dose cohort in the MARVEL-1 study immediately, with first patient dosing expected in mid-2022 LONDON, March 24, 2022 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), today announced an updated clinical development plan and timelines for FLT190 for people with Fabry disease, a rare, inherited lysosomal storage disorder resulting in cell abnormalities and organ dysfunction that affect small blood vessels, tissues and organs including skin, kidneys, heart, and the nervous system. The Company will proceed immediately to the second dose cohort (1.5e12 vg/kg) in the MARVEL-1 dose escalation study, with the first patient expected to be dosed in mid-2022. Previous plans to dose an additional patient in the first cohort (7.5e11 vg/kg) have been revised based...

Continue reading

GURU Energizes Canadians Coast-to-Coast With “Made With Plants” Campaign

GURU Organic Energy GURU launches national “Made with Plants” campaignGURU Organic Energy GURU launches national “Made with Plants” campaignGURU Organic Energy GURU launches national “Made with Plants” campaignGURU Organic Energy GURU launches national “Made with Plants” campaignFirst of three major 2022 marketing campaigns to build on GURU’s momentum as the fastest-growing organic energy drink in Canada1 National campaign also marks Canada-wide launch of top energy drink industry innovation: GURU Guayusa Tropical PunchMONTREAL, March 24, 2022 (GLOBE NEWSWIRE) — GURU Organic Energy Corp. (TSX: GURU) (“GURU” or the “Company”), Canada’s leading organic energy drink brand, announces the launch of Made with Plants, a national campaign that highlights GURU’s exclusive market position as the only plant-based drink...

Continue reading

GameOn Partners With Tetavi to Launch Innovative NFT Music Discovery Game

VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — GameOn Entertainment Technologies Inc. (“GameOn” or the “Company”) (CSE: GET) (OTCQB: GMETF), a leading NFT game technology company partnered with the world’s biggest IPs to launch, operate and monetize NFT-based games, has today announced a partnership with immersive content pioneer, Tetavi, for a first-of-its-kind NFT music discovery game. Established in 2016, Tetavi is a new media, technology company and the leader in volumetric video capture. Tetavi uses cutting-edge volumetric video technology and proprietary algorithms built on thousands of hours of machine learning to create next generation photorealistic digital content and immersive experiences. Their mission is to enable connection, self-expression, and creativity in the Metaverse and Web3. Through the partnership,...

Continue reading

ValOre Expands Pedra Branca Inferred Mineral Resource by 106% to 2.2 Million Ounces at 1.08 g/t 2PGE+Au

VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — ValOre Metals Corp. (“ValOre”; TSX‐V: VO; OTC: KVLQF; Frankfurt: KEQ0, “the Company”) today reported an updated independent National Instrument 43-101 (“NI 43-101”) inferred mineral resource estimate for ValOre’s 100%-owned Pedra Branca Platinum Group Elements (“PGE”, “2PGE+Au”) Project (“Pedra Branca”) in northeastern Brazil. ValOre’s CEO, Jim Paterson stated, “We are very pleased to announce the doubling of ValOre’s Pedra Branca inferred mineral resource estimate, which was expanded to 2.2 million ounces of palladium, platinum, and gold at 1.08 g/t 2PGE+Au. Several of the zones which form part of the resource estimate remain wide open for expansion in future drill programs. ValOre’s technical team has demonstrated their ability to expand known resource zones and to...

Continue reading

ProMIS Neurosciences to Present at the 10th Annual Neurodegenerative Drug Development Summit

TORONTO, Ontario and CAMBRIDGE, MA , March 24, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it will be presenting at the upcoming 10th Annual Neurodegenerative Drug Development Summit, to be held in Boston, MA, March 28-30, 2022. ProMIS Chief Scientific Officer, Dr. Neil Cashman, will deliver an oral presentation entitled: “Abeta oligomers in Alzheimer Disease: Target Engagement and Target Distraction”, on Tuesday, March 29, 2022, at 3 PM local time at the Boston Park Plaza Hotel. Much scientific data has implicated misfolded oligomers as the toxic molecular species of amyloid beta (Abeta)...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.